Description
Cagrilintide · Semaglutide Blend co-formulates a long-acting amylin analogue with a GLP-1 receptor agonist in one vial, mirroring the dual-pathway combination prominent in current metabolic research.
Published clinical-stage data on this pairing explore whether simultaneous amylin and incretin signalling produces greater appetite-regulation effects than either pathway alone.
Format & handling
Supplied as a lyophilized powder in a sealed, batch-stamped vial. Store sealed at −20 °C protected from light. For laboratory work, reconstitute with bacteriostatic water shortly before use and refrigerate any working solution at 2–8 °C.
For laboratory research use only — not for human or veterinary use. The summary above describes published research for scientific context and makes no claims about this product.
